Search Results - "Peytavin, G."

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon by Calmy, Alexandra, Tovar Sanchez, Tamara, Kouanfack, Charles, Mpoudi-Etame, Mireille, Leroy, Sandrine, Perrineau, Ségolène, Lantche Wandji, Martial, Tetsa Tata, Darius, Omgba Bassega, Pierette, Abong Bwenda, Thérèse, Varloteaux, Marie, Tongo, Marcel, Mpoudi-Ngolé, Eitel, Montoyo, Alice, Mercier, Noémie, LeMoing, Vincent, Peeters, Martine, Reynes, Jacques, Delaporte, Eric, Calmy, A, Tovar Sanchez, T, Kouanfack, C, Mpoudi-Etame, M, Leroy, S, Perrineau, S, Lantche-Wandji, M, Tetsa-Tata, D, Omgba-Bassega, P, Abong-Bwenda, T, Varloteaux, M, Tongo, M, Mpoudi-Ngolé, E, Montoyo, A, Mercier, N, LeMoing, V, Peeters, M, Reynes, J, Delaporte, E, Ayouba, A, Agholeng, A, Butel, C, Cournil, A, Eymard-Duvernay, S, Granouillac, B, Izard, S, Lacroix, A, Serrano, L, Vidal, N, Fouda, PJ, Mougnoutou, R, Olinga, J, Omgba, V, Tchokonte-Ngandé, SC, Ymele, B, Epoupa-Mpacko, CD, Fotso, M, Moukoko, R, Nké, T, Akamba, A, Lekelem, S, Tongo-Fotack, SB, Ngono, S, Tanga, M, Ebong, E, Edoul-Mbesse, G, Ciaffi, L, Koulla-Shiro, S, Manirakiza, G, Mimbé, ED, Boyer, S, Bousmah, M, Maradan, G, Nishimwe, ML, Spire, B, Lê, MP, Peytavin, G, Diallo, A, Fournier, I, Rekacewicz, C, Perez Casas, C

“…BACKGROUNDUpdated WHO guidelines recommend a dolutegravir-based regimen as the preferred first-line treatment for HIV infection and low-dose efavirenz (400 mg)…”
Get full text

Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations by Palich, R, Wirden, M, Peytavin, G, Lê, M -P, Seang, S, Abdi, B, Schneider, L, Tubiana, R, Valantin, M -A, Paccoud, O, Soulié, C, Calvez, V, Katlama, C, Marcelin, A -G

“…Abstract Objectives To assess genotypic sensitivity scores (GSSs), plasma antiretroviral concentrations (PACs) and immunovirological outcomes at Week 96 (W96)…”
Get full text

Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice by Alain, S, Feghoul, L, Girault, S, Lepiller, Q, Frobert, E, Michonneau, D, Berceanu, A, Ducastelle-Lepretre, S, Tilloy, V, Guerin, E, Le Goff, J, Peytavin, G, Hantz, S

“…To analyse mechanisms of letermovir breakthrough during compassionate primary and secondary prophylaxis. Mechanisms of letermovir breakthrough during…”
Get full text

Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia by Katlama, C, Soulié, C, Caby, F, Denis, A, Blanc, C, Schneider, L, Valantin, M-A, Tubiana, R, Kirstetter, M, Valdenassi, E, Nguyen, Thuy, Peytavin, G, Calvez, V, Marcelin, A-G

“…Reducing drug burden is a key challenge for achieving lifelong suppressive HIV therapy. Dolutegravir, with a high potency, long half-life and high genetic…”
Get full text

Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection by Bachelard, A, Isernia, V, Vallois, D, Le Gac, S, Chalal, L, Landman, R, Damond, F, Descamps, D, Yazdanpanah, Y, Peytavin, G, Ghosn, J

Get full text

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death by Chalouni, Mathieu, Pol, Stanislas, Sogni, Philippe, Fontaine, Hélène, Lacombe, Karine, Marc-Lacombe, Jean, Esterle, Laure, Dorival, Celine, Bourlière, Marc, Bani-Sadr, Firouzé, de Ledinghen, Victor, Zucman, David, Larrey, Dominique, Salmon, Dominique, Carrat, Fabrice, Wittkop, Linda, Salmon, D., Wittkop, L., Sogni, P., Esterle, L., Trimoulet, P., Izopet, J., Serfaty, L., Paradis, V., Spire, B., Carrieri, P., Valantin, M.A., Pialoux, G., Chas, J., Poizot-Martin, I., Barange, K., Naqvi, A., Rosenthal, E., Bicart-See, A., Bouchaud, O., Gervais, A., Lascoux-Combe, C., Goujard, C., Lacombe, K., Duvivier, C., Neau, D., Morlat, P., Bani-Sadr, F., Meyer, L., Boufassa, F., Autran, B., Roque, A.M., Solas, C., Fontaine, H., Costagliola, D., Piroth, L., Simon, A., Zucman, D., Boué, F., Miailhes, P., Billaud, E., Aumaitre, H., Rey, D., Peytavin, G., Petrov-Sanchez, V., Lebrasseur-Longuet, D.

“…Direct-acting antivirals (DAA) lead to high sustained virological response (SVR) rates and decrease the risk of disease progression. We compared SVR rates and…”
Get full text

Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study by Pourcher, V., Capeau, J., Dudoit, Y., Boccara, F., Soulié, C., Ndoadoumgue, A.L., Charlotte, F., Fellahi, S., Bastard, J. P., Béréziat, V., Lagathu, C., Marcelin, A. G., Peytavin, G., Boutron-Ruault, M. C., Tubbax, C., D'Avout D'Auerstaedt, A., Valantin, M. A., Schneider, L., Costagliola, D., Katlama, C., Assoumou, L., Pourcher, G.

“…The aim of this study was to compare clinical characteristics and adipose/liver tissue histology analysis in HIV-infected and HIV-uninfected subjects…”
Get full text

Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing by Nguyen, T, Fofana, D B, Lê, M P, Charpentier, C, Peytavin, G, Wirden, M, Lambert-Niclot, S, Desire, N, Grude, M, Morand-Joubert, L, Flandre, P, Katlama, C, Descamps, D, Calvez, V, Todesco, E, Marcelin, A G

“…Integrase strand transfer inhibitors (INSTIs) are recommended by international guidelines as first-line therapy in antiretroviral-naive and -experienced…”
Get full text

Long-term follow-up of HIV-infected patients on dolutegravir monotherapy by Tebano, G, Soulié, C, Schneider, L, Blanc, C, Agher, R, Seang, S, Valantin, M A, Palich, R, Tubiana, R, Peytavin, G, Marcelin, A G, Assoumou, L, Katlama, C

“…Abstract Background In recent years, dolutegravir monotherapy has been explored as a drug-reduced regimen for HIV patients. Methods This was a retrospective…”
Get full text

Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa by Fofana, D B, d'Almeida, M, Lambert-Niclot, S, Peytavin, G, Girard, P M, Lafia, B, Zohoun-Guidigbi, L, Keke, R K, Soulie, C, Marcelin, A G, Morand-Joubert, L

“…In Africa a high percentage of HIV-infected children continue to experience HIV treatment failure despite enormous progress. In Benin (West Africa), there are…”
Get full text

Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit by Dang, E., Sayagh, F., Lê, M. P., Neuville, M., Sinnah, F., Timsit, J-F., Peytavin, G.

“…We present the case of a 21-year-old man admitted to the intensive care unit with multi-organ failure due to multidrug-resistant tuberculosis (TB). TB…”
Get full text

Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs by Tricot, L., Teicher, E., Peytavin, G., Zucman, D., Conti, F., Calmus, Y., Barrou, B., Duvivier, C., Fontaine, C., Welker, Y., Billy, C., De Truchis, P., Delahousse, M., Vittecoq, D., Salmon‐Céron, D.

“…Solid organ transplantations (SOT) are performed successfully in selected HIV‐infected patients. However, multiple and reciprocal drug–drug interactions are…”
Get full text

Placental Transfer of Maraviroc in an Ex Vivo Human Cotyledon Perfusion Model and Influence of ABC Transporter Expression by VINOT, C, GAVARD, L, GIRAUD, C, TRELUYER, J. M, MANCEAU, S, COURBON, E, SCHERRMANN, J. M, DECLEVES, X, DURO, D, PEYTAVIN, G, MANDELBROT, L

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy by Pain, J B, Lê, M P, Caseris, M, Amiel, C, Lassel, L, Charpentier, C, Desnoyer, A, Farnoux, C, Pialoux, G, Descamps, D, Peytavin, G

“…We describe the pharmacokinetics of dolutegravir (DTG) in a premature neonate after maternal intensification of an antiretroviral (ARV) regimen by adding DTG…”
Get full text

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey by Marcelin, Anne-Genevieve, Charpentier, Charlotte, Bellecave, Pantxika, Abdi, Basma, Chaix, Marie-Laure, Ferre, Virginie, Raymond, Stephanie, Fofana, Djeneba, Bocket, Laurence, Mirand, Audrey, Le Guillou-Guillemette, Helene, Montes, Brigitte, Amiel, Corinne, Pallier, Coralie, Fafi-Kremer, Samira, De Monte, Anne, Alessandri-Gradt, Elodie, Scholtes, Caroline, Maillard, Anne, Jeulin, Helene, Bouvier-Alias, Magali, Roussel, Catherine, Dos Santos, Georges, Signori-Schmuck, Anne, Dina, Julia, Vallet, Sophie, Stefic, Karl, Soulié, Cathia, Calvez, Vincent, Descamps, Diane, Flandre, Philippe

“…Abstract Background Successful 2-drug regimens (2DRs) for HIV were made possible by the availability of drugs combining potency and tolerability with a high…”
Get full text

Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis by Perrineau, S., Lachâtre, M., Lê, M. P., Rioux, C., Loubet, P., Fréchet-Jachym, M., Gonzales, M. Cervantes, Grall, N., Bouvet, E., Veziris, N., Yazdanpanah, Y., Peytavin, G.

“…SETTING: Bedaquiline (BDQ) has been approved for the treatment of multidrug- and extensively drug-resistant tuberculosis (MDR/XDR-TB). For many patients…”
Get full text

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence? by Visseaux, Benoit, Assoumou, Lambert, Mahjoub, Nadia, Grude, Maxime, Trabaud, Mary-Anne, Raymond, Stéphanie, Wirden, Marc, Morand-Joubert, Laurence, Roussel, Catherine, Montes, Brigitte, Bocket, Laurence, Fafi-Kremer, Samira, Amiel, Corinne, De Monte, Anne, Stefic, Karl, Pallier, Coralie, Tumiotto, Camille, Maillard, Anne, Vallet, Sophie, Ferre, Virginie, Bouvier-Alias, Magali, Dina, Julia, Signori-Schmuck, Anne, Carles, Marie-Josée, Plantier, Jean-Christophe, Meyer, Laurence, Descamps, Diane, Chaix, Marie-Laure

“…Abstract Objectives Patients with primary HIV-1 infection (PHI) are a particular population, giving important insight about ongoing evolution of transmitted…”
Get full text

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro by Roquebert, B., Damond, F., Collin, G., Matheron, S., Peytavin, G., Bénard, A., Campa, P., Chêne, G., Brun-Vézinet, F., Descamps, D.

“…Objectives We investigated the in vitro phenotypic susceptibility of HIV-2 isolates from integrase inhibitor (INI)-naive patients to INIs and its relation to…”
Get full text

Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole-related panniculitis by Polivka, L., Peytavin, G., Franck, N., Mouthon, L., Dupin, N.

Get full text

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study by Gantner, P, Pugliese, P, Bani‐Sadr, F, Joly, V, Poizot‐Martin, I, Garraffo, R, Peytavin, G, Fafi‐Kremer, S, Rey, D, Bonnet, B., Bouchez, S., Hall, N., Aubry, O., Point, P., Besnier, M., Grossi, O., Lefebvre, M., Hüe, H., Soria, A., Pineau, S., André‐Garnier, E., Rodallec, A., Brégigeon, S., Faucher, O., Orticoni, M., Soavi, M. J., Ressiot, E., Pinot, I., Ducassou, M. J., Bertone, H., Gallie, S., Ritleng, A. S., Ivanova, A., Blanco‐Betancourt, C., Alvarez, M., Biezunski, N., Debard, A., Delobel, P., Delpierre, C., Marchou, B., Martin‐Blondel, G., Mularczyk, M., Garipuy, D., Saune, K., Marcel, M., Puntis, E., Ceppi, C., Cottalorda, J., Dellamonica, P., Demonchy, E., Dunais, B., Ferrando, S., Fuzibet, J. G., Risso, K., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Wehrlen‐Pugliese, S., Rosenthal, E., Roger, P. M., Vandame, S., Ajana, F., Baclet, V., Huleux, T. H., Melliez, H., Viget, N., Aissi, E., Meybeck, A., Agher, R., Katlama, C., Mackoumbou‐Nkouka, C., Louni, F., Descamps, D., Cotte, L., Peyramond, D., Chidiac, C., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Dahoud, F., Lippmann, J., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Batard, M. L., Cheneau, C., Mautort, E., Fischer, P., Partisani, M., Priester, M., Bani‐Sadr, F., Berger, J. L., Hentzien, M.

Get full text